ArticleMedicine2025
Bibliometric analysis of atrial fibrillation and frailty research based on CiteSpace and VOSviewer.
Article in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundResearch on atrial fibrillation (AF) and frailty has increasingly attracted scholarly and clinical attention in recent years, driven by the need to understand their complex interactions and improve care for vulnerable populations. This study aims to systematically analyze the evolving landscape of AF (frailty research).
methodsWe extracted data from the Web of Science Core Collection, identifying 687 relevant articles published between 2001 and 2024. Employing bibliometric tools (VOSviewer and CiteSpace), we mapped knowledge networks, analyzing publication trends, contributor geography (46 countries/regions), institutional involvement (1540 institutions), and researcher collaboration (4096 researchers).
resultsPublication Trends: Growth Trajectory: Consistent growth in AF-frailty (related publications over the 2001 to 2024 period. Geographic & Institutional Contributions: The United States led in research output, with global participation across 46 countries/regions and 1540 institutions).
conclusionsAF (frailty research has matured into a multidisciplinary field with expanding global contributions). Future advancements require intensified multidisciplinary collaboration and integration of precision medicine frameworks. Prioritizing these will enable optimized, personalized care for frail AF patients, addressing unmet clinical needs in this high-risk population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.